Comorbidity and the risk of venous thromboembolism in prostate cancer

Author： Alibhai Shabbir M. H.   O'Neill Meagan E.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|20|3574-3576

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3574-3576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011

By Ording Anne G.   Horváth-Puhó Erzsébet   Lash Timothy L.   Ehrenstein Vera   Borre Michael   Vyberg Mogens   Sørensen Henrik T.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3692-3699

Blackwell Publishing

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

By  

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Oral HRT doubles venous thromboembolism risk

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Risk of venous thromboembolism due to antipsychotic drug therapy

By Hägg Staffan   Jönsson Anna K   Spigset Olav  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite